Specifically, the expression of SMAD4 significantly diminishes the rate of extracellular acidification and elevates the rate of oxygen consumption in pancreatic cancer, leading to metabolic reprogramming in this context. Here, SMAD4 is linked to familial pancreatic carcinoma.